Capital raised by Mitera Biosciences
1 Form D filing · first filed Apr 2026 · Bellevue, WA
Chief Executive Officer
Signatory on Mitera Biosciences's Form D filings · $1.1M raised across 1
Kevin Chow is on file as Chief Executive Officer at Mitera Biosciences in Bellevue, WA. Mitera Biosciences has 1 Form D filing on record, $1.1M raised in total. Kevin Chow appears as a signatory on the company's filings.
LinkedIn profileNo other people are on file at Mitera Biosciences. Form D filings only name the signatory and the company's executive officers.
An early-stage drug program derived from a natural human protein produced by the placenta during pregnancy and expressed in the thymus, developed as an immunosuppressive therapeutic for solid organ transplant rejection and autoimmune disorders.
